View Older Stories View More Recent Stories

Feb 15, 2025 10:16AM ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Feb 15, 2025 10:04AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Feb 14, 2025 09:55AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Feb 13, 2025 05:49PM ROSEN, A LEADING NATIONAL FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Feb 13, 2025 02:00PM Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman
Feb 12, 2025 12:00PM NVO INVESTOR DEADLINE: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Feb 12, 2025 04:39AM Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK620 at Bernstein SocGen Group
Feb 12, 2025 03:01AM Morgan Stanley Starts Novo Nordisk (NOVOB:DC) (NVO) at Equalweight
Feb 11, 2025 09:56PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Feb 11, 2025 07:16AM NVO CLASS ACTION UPDATE: Novo Nordisk Investors are Reminded to Contact BFA Law before Imminent March 25 Deadline
Feb 11, 2025 06:00AM Bernstein explains why this Big Pharma stock should 'continue to work'
Feb 10, 2025 09:20PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Feb 10, 2025 12:09PM ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Feb 9, 2025 09:15AM ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Feb 9, 2025 08:16AM Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - NVO
Feb 9, 2025 07:16AM Novo Nordisk (NVO) Investors are Alerted of the Pending Class Action and are Urged to Contact BFA Law by March 25 Deadline
Feb 7, 2025 12:00PM Bernstein explains why this big pharma stock continue to work
Feb 7, 2025 07:37AM NVO INVESTOR DEADLINE: Novo Nordisk Investors are Alerted to Contact BFA Law before the Imminent March 25 Class Action Deadline
Feb 6, 2025 05:23PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Feb 6, 2025 04:00PM NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Feb 6, 2025 02:57PM Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman
Feb 6, 2025 02:13AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK1,000 at JPMorgan
Feb 5, 2025 08:07PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Feb 5, 2025 08:33AM NVO CLASS ACTION: BFA Law Alerts Novo Nordisk Investors of the Imminent March 25 Class Action Deadline
Feb 5, 2025 02:04AM Novo Nordisk (NVO) Reports Q4 EPS of DKK6.34; offers outlook
Feb 4, 2025 11:00PM Novo Nordisk earnings preview: BofA analysts weigh in ahead of Q4 results
Feb 4, 2025 04:01PM NVO INVESTOR ALERT: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Feb 4, 2025 10:54AM Novo Nordisk (NVO) call put ratio 1.7 calls to 1 put into quarter results
Feb 4, 2025 04:42AM Novo Nordisk (NVO) call put ratio 1.5 calls to 1 put into quarter results
Feb 2, 2025 08:21AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Jan 31, 2025 08:32AM Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman
Jan 30, 2025 05:49PM NVO INVESTOR NOTICE: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 30, 2025 04:39PM ROSEN, A TOP RANKED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Jan 30, 2025 01:12PM Eli Lilly & Co. (LLY), Novo (NVO) see mid-day upside
Jan 29, 2025 04:00PM NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 28, 2025 08:45PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Jan 28, 2025 04:59PM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO) following latest Ozempic approval
Jan 28, 2025 02:28PM FDA approves Novo Nordisk's (NVO) Ozempic as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
Jan 28, 2025 09:08AM Novo Nordisk (NVO) sees pre-open selling pressure
Jan 26, 2025 10:24AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Jan 24, 2025 12:14PM BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)
Jan 24, 2025 09:09AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO) Amid Solid SubQ Amycretin Results
Jan 24, 2025 07:13AM Novo Nordisk (NVO) successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
Jan 24, 2025 06:33AM Novo Nordisk (NVO) call put ratio 1 call to 1 put into share price up before the bell
Jan 23, 2025 05:17AM Novo Nordisk (NVO) call put ratio 2.5 calls to 1 put
Jan 21, 2025 04:51AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 21, 2025 04:20AM Novo Nordisk (NVO) PT Lowered to $90 at CFRA
Jan 17, 2025 08:08AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 17, 2025 08:02AM Novo's (NVO) Ozempic, Wegovy Targeted In Medicare Price Negotiations - Bloomberg
Jan 17, 2025 07:16AM Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK798 at Guggenheim
View More Recent Stories View Older Stories